The relation of pituitary adenomas invasiveness and the proliferative index measured by immunoexpression of topoisomerase IIα.

INTRODUCTION Cavernous sinus invasion by pituitary adenoma affects surgical procedure radicality and consequently the postoperative course and prognosis in pituitary adenoma treatment. The search for pituitary adenoma aggressive behaviour markers is still a matter of debate. MATERIAL AND METHODS This study evaluates the relation of pituitary adenoma invasiveness to the expression of topoisomerase IIα in 72 patients who underwent transsphenoidal pituitary surgery. The assessment of tumour growth was conducted according to the Hardy scale as modified by Wilson and the Knosp scale. Topoisomerase IIα expression in tumour specimens was evaluated using immunohistochemical staining. RESULTS There was a correlation between the Knosp scale degree and the topoisomerase IIα expression (Spearman R = 0.3611, p < 0.005). The Kruskal-Wallis H test (p = 0.0034) showed that there was a statistically significant topoisomerase IIα expression increase in tumours classified as grade E on the Hardy scale. The topoisomerase IIα expression correlated also with tumour size (Spearman R = 0.4117, p < 0.001). Higher levels of expression were observed in macroadenomas, as compared to microadenomas (p < 0.05, Mann-Whitney test). Topoisomerase IIα expression correlated with cavernous sinus invasion. CONCLUSIONS The topoisomerase IIα expression correlated more with invasiveness than with extensiveness, which might make it an eminently useful marker in the assessment of aggressive pituitary adenoma behaviour.

[1]  C. Melincovici,et al.  Diagnostic criteria in invasive pituitary adenomas , 2016 .

[2]  A. Chacko,et al.  Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas , 2015, Journal of Clinical Neuroscience.

[3]  S. Ceylan,et al.  Cavernous sinus invasion and effect of immunohistochemical features on remission in growth hormone secreting pituitary adenomas. , 2015, Turkish neurosurgery.

[4]  A. Hubalewska-Dydejczyk,et al.  Topoisomerase IIα as a prognostic factor in pituitary tumors. , 2014, Polskie Archiwum Medycyny Wewnetrznej.

[5]  Jinna Kim,et al.  Evaluation of MRI Criteria for Cavernous Sinus Invasion in Pituitary Macroadenoma , 2014, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[6]  Wei Gao,et al.  Expression of DNA topoisomerase II-α: Clinical significance in laryngeal carcinoma , 2014, Oncology letters.

[7]  A. Heaney Management of aggressive pituitary adenomas and pituitary carcinomas , 2014, Journal of Neuro-Oncology.

[8]  B. Scheithauer,et al.  Clinicopathologic correlates of giant pituitary adenomas , 2009, Journal of Clinical Neuroscience.

[9]  A. Falini,et al.  Tumours , 2008, Neurological Sciences.

[10]  Patrick J. Maloney Handbook of Neurosurgery , 2008, The Yale Journal of Biology and Medicine.

[11]  Michael Buchfelder,et al.  Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. , 2007, European journal of endocrinology.

[12]  A. Doerfler,et al.  Imaging of sellar and parasellar lesions , 2007, Clinical Neurology and Neurosurgery.

[13]  PhD George Kontogeorgos MD Classification and pathology of pituitary tumors , 2007, Endocrine.

[14]  G. Kontogeorgos Predictive Markers of Pituitary Adenoma Behavior , 2006, Neuroendocrinology.

[15]  H. Koh,et al.  Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma , 2005, Journal of Korean medical science.

[16]  M. Buchfelder,et al.  Clinical review: Diagnosis and management of pituitary carcinomas. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  R. Fahlbusch,et al.  The WHO classification of pituitary tumours: a combined neurosurgical and neuropathological view , 2005, Acta Neuropathologica.

[18]  A. Grossman The 2004 World health organization classification of pituitary tumors: is it clinically helpful? , 2005, Acta Neuropathologica.

[19]  R. Fahlbusch,et al.  Transsphenoidal surgery of parasellar pituitary adenomas , 2005, Acta Neurochirurgica.

[20]  J. Hainfellner,et al.  Expression of cell proliferation markers in pituitary adenomas – correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIα , 2004, Acta Neurochirurgica.

[21]  A. Goel,et al.  Giant pituitary tumors: a study based on surgical treatment of 118 cases. , 2004, Surgical neurology.

[22]  J. Wass,et al.  Are Markers of Proliferation Valuable in the Histological Assessment of Pituitary Tumours? , 1999, Pituitary.

[23]  B. Scheithauer,et al.  Topoisomerase IIα Expression in Pituitary Adenomas and Carcinomas: Relationship to Tumor Behavior , 2002, Modern Pathology.

[24]  S. Ozalp,et al.  Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma. , 2002, European journal of gynaecological oncology.

[25]  M. Koshiyama,et al.  Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas. , 2001, Anticancer research.

[26]  G. Stalla,et al.  Hypophysentumoren und Kraniopharyngeome. , 2001 .

[27]  L. Brunereau,et al.  Cavernous sinus invasion by pituitary adenoma: MR imaging. , 2000, Radiology.

[28]  Rebecca Lynn Johnson,et al.  Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome Variables , 2000, Modern Pathology.

[29]  C. Matula,et al.  Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. , 1993, Neurosurgery.

[30]  G. Faglia Epidemiology and pathogenesis of pituitary adenomas. , 1993, Acta endocrinologica.

[31]  A. Elster Imaging of the sella: anatomy and pathology. , 1993, Seminars in ultrasound, CT, and MR.

[32]  F. Boege,et al.  The measurement of nuclear topoisomerase II inhibition in vitro: a possible tool for detecting resistance on a subcellular level in haematopoietic malignancies. , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[33]  P. Kleihues,et al.  Growth rate of human pituitary adenomas. , 1987, Journal of neurosurgery.

[34]  C. Zee,et al.  Cavernous sinus invasion by pituitary adenomas. , 1985, AJR. American journal of roentgenology.

[35]  G. di Chiro,et al.  The volume of the sella turcica. , 1962, The American journal of roentgenology, radium therapy, and nuclear medicine.